Epidemiology of pulmonary embolism in the US

Latest 5 articles from heartwire

Fidelis failures climb: "Strongly consider" replacement at ICD change-out
Feb 10, 2012 17:00 EDT
New mitral-repair therapies face obstacles
Feb 10, 2012 16:30 EDT
More doctors advising patients to exercise
Feb 10, 2012 14:45 EDT
More hope for factor Xa reversal
Feb 10, 2012 14:00 EDT
The doctor will see you now (from the other side of the world)
Feb 10, 2012 12:30 EDT

Epidemiology of pulmonary embolism in the US

Posted Nov 04, 2009 at 02:00 PM, EDT by Samuel Goldhaber

Important data published in Chest show that the rate of diagnosis of pulmonary embolism at discharge from hospital has doubled and that costs of treating have risen. The positive news is that the death rate from PE has dramatically decreased.

See:

Park B, Messina L, Phong D, et al. Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States. Chest 2009; 136:983-990. Available here

No comments | Add your own comments |

Share this post:

Permalink

« Previous

Comments

Add your own comments

E-mail: (not shared)

Display name:

Notify me of replies (via email):

Your comment:

This blog on theheart.org is a sounding board for healthcare providers, clinicians, and researchers, and is not intended to supply answers or advice to patients. We reserve the right to remove posts containing inappropriate language, promotional content, personal agendas or hostile intent, and posts from patients asking for medical advice.

In the interest of promoting a balanced exchange, please disclose any relevant relationships or conflicts of interest when posting your comment.

The views and opinions expressed herein are those of the blogger and do not necessarily reflect those of theheart.org.

Preventing postthrombotic syndrome: CAVENT supports the "open vein hypothesis"

No comments | Posted Feb 10, 2012
at 09:20 AM, EDT by Samuel

IVC filters: The genie's out of the bottle

No comments | Posted Feb 03, 2012
at 08:30 AM, EDT by Samuel

Emergency hospitalization from adverse drug events: Warfarin the biggest culprit

No comments | Posted Jan 27, 2012
at 08:50 AM, EDT by Samuel

Self-monitoring INR and self-managing warfarin to reduce thromboembolic events

4 Comments | Posted Jan 20, 2012
at 07:30 AM, EDT by Samuel

LIFENOX: No advantage of VTE prophylaxis in hospitalized medical service patients

1 Comments | Posted Jan 13, 2012
at 09:20 AM, EDT by Samuel

Also from theheart.org

Trials and PIs

Topolog

The Bob Harrington Show

Private practice with Dr Seth Bilazarian

This week in cardiology from heartwire

Cutting-edge dialogues with Drs Tim Gardner and Mat Williams

Heartfelt with Dr Melissa Walton-Shirley

Fellows' corner

Topol and Teirstein: The Click and Rub Show

Heart failure and transplantation with Dr Ileana Piña

Blogs I read

North American Thrombosis Forum

Who's Talking

Samuel Z Goldhaber, MD
Professor of Medicine
Harvard Medical School
Director, Venous Thromboembolism Research Group
Co-Director, Anticoagulation Management Service
Cardiovascular Division
Brigham and Women's Hospital
Boston, MA